Immunoglobulin
Basic Information
| Item | Value |
|---|---|
| DrugBank ID | DB00028 |
| Evidence Level | L5 (Computational Prediction) |
| Number of Predicted Indications | 99 |
Predicted Indications (TxGNN)
The following are potential new indications predicted by the TxGNN model. Higher scores indicate higher predicted relevance.
| # | Indication | Source |
|---|---|---|
| 1 | severe nonproliferative diabetic retinopathy | KG + DL |
| 2 | diabetic retinopathy | KG + DL |
| 3 | drug-induced osteoporosis | KG + DL |
| 4 | diabetic cataract | KG + DL |
| 5 | nuclear senile cataract | KG + DL |
| 6 | cortical cataract | KG + DL |
| 7 | senile cataract | KG + DL |
| 8 | mature cataract | KG + DL |
| 9 | immature cataract | KG + DL |
| 10 | diabetes mellitus type 2 associated cataract | KG + DL |
| 11 | craniostenosis cataract | KG + DL |
| 12 | tetanic cataract | KG + DL |
| 13 | HER2 positive breast carcinoma | KG + DL |
| 14 | hemorrhagic disease of newborn | KG + DL |
| 15 | kidney pelvis sarcomatoid transitional cell carcinoma | KG + DL |
| 16 | prostatic urethra urothelial carcinoma | KG + DL |
| 17 | infiltrating bladder urothelial carcinoma sarcomatoid variant | KG + DL |
| 18 | renal pelvis papillary urothelial carcinoma | KG + DL |
| 19 | transitional cell carcinoma | KG + DL |
| 20 | dermatitis | KG + DL |
| 21 | progesterone-receptor positive breast cancer | KG + DL |
| 22 | normal breast-like subtype of breast carcinoma | KG + DL |
| 23 | breast tumor luminal A or B | KG + DL |
| 24 | progesterone-receptor negative breast cancer | KG + DL |
| 25 | neonatal dermatomyositis | KG + DL |
| 26 | hydroa vacciniforme, familial | KG + DL |
| 27 | acrodermatitis chronica atrophicans | KG + DL |
| 28 | primary release disorder of platelets | KG + DL |
| 29 | acne keloid | KG + DL |
| 30 | amyopathic dermatomyositis | KG + DL |
| 31 | microvascular complications of diabetes, susceptibility to | KG + DL |
| 32 | secondary interstitial lung disease specific to childhood associated with a connective tissue disease | KG + DL |
| 33 | chondroid hamartoma | KG + DL |
| 34 | ductal or ductular proliferation | KG + DL |
| 35 | non-seminomatous lesion | KG + DL |
| 36 | bronchial adenomas/carcinoids childhood | KG + DL |
| 37 | Glanzmann thrombasthenia | KG + DL |
| 38 | tumor of testis and paratestis | KG + DL |
| 39 | thyroglossal duct cyst | KG + DL |
| 40 | benign neoplasm of tongue | KG + DL |
| 41 | cystic neoplasm | KG + DL |
| 42 | mesenchymoma | KG + DL |
| 43 | cervical neuroblastoma | KG + DL |
| 44 | inner ear neoplasm | KG + DL |
| 45 | pseudo-von Willebrand disease | KG + DL |
| 46 | schwannoma of jugular foramen | KG + DL |
| 47 | epiglottis neoplasm | KG + DL |
| 48 | benign neoplasm of floor of mouth | KG + DL |
| 49 | benign neoplasm of hypopharynx | KG + DL |
| 50 | benign neoplasm of buccal mucosa | KG + DL |
(Showing top 50 of 99 predictions)
Disclaimer
These predictions are for research purposes only and do not constitute medical advice. Clinical validation is required before any clinical application.